Other Finding — Fat Necrosis
Fat necrosis is a benign process resulting from focal necrosis of adipose tissue, typically at sites of prior trauma, surgery, radiation therapy, or biopsy. It is one of the most common benign findings encountered on breast MRI and is classified under Other Findings — Typically Benign in BI-RADS v2025.
Definition
Fat necrosis represents saponification and fibrosis of damaged breast fat. It produces a spectrum of imaging appearances depending on the stage of evolution — from acute liquefied fat collections to mature oil cysts with calcified walls. Despite its benign nature, fat necrosis is a well-known mimic of malignancy on all breast imaging modalities, including MRI.
MRI Appearance
Signal Characteristics
| Sequence | Appearance |
|---|---|
| T1W (non-fat-suppressed) | High signal — follows subcutaneous fat (diagnostic clue) |
| T1W fat-suppressed | Signal drops out, confirming intralesional fat |
| T2W | Variable; may be high signal if liquefied, intermediate if fibrotic |
| DWI | Typically no restricted diffusion; ADC values usually >1.5 × 10⁻³ mm²/s |
| Post-contrast (subtraction) | Variable enhancement — none to pronounced rim or heterogeneous |
Enhancement Patterns
- No enhancement — mature oil cyst, most straightforward diagnosis
- Thin rim enhancement — common, benign pattern surrounding an oil cyst
- Thick rim enhancement — can closely mimic malignancy; look for internal fat signal to differentiate
- Heterogeneous enhancement — early or evolving fat necrosis with surrounding inflammatory change
- Enhancement can appear, change, or resolve years after the inciting trauma or surgery
Morphology
- May present as a mass (round or oval with circumscribed margins) or as a non-mass enhancement pattern
- Oil cyst: well-defined, round or oval collection with fat signal and thin or calcified wall — pathognomonic
- Surrounding architectural distortion may be present, particularly at surgical sites
- May coexist with dystrophic calcifications visible on mammography
Board Pearl
The single most important diagnostic step when encountering rim enhancement at a surgical site is to review the non-fat-suppressed T1W sequence. Internal fat signal = fat necrosis. This one maneuver prevents unnecessary biopsies.
Confirmation Strategy
- Identify the lesion on post-contrast or subtraction images
- Correlate with non-fat-suppressed T1W — look for high signal matching subcutaneous fat
- Confirm signal loss on fat-suppressed T1W sequences
- Review clinical history for prior surgery, trauma, biopsy, or radiation at that site
- Correlate with mammography for associated oil cyst or dystrophic calcifications
- If all criteria met → BI-RADS 2 (benign), no further workup needed
Differential Diagnosis
| Entity | Key Distinguishing Feature |
|---|---|
| Fat necrosis | Internal fat signal on T1W; history of trauma/surgery |
| Invasive carcinoma with rim enhancement | No internal fat signal; restricted diffusion on DWI; irregular margins |
| Abscess | Central T2 hyperintensity (fluid, not fat); restricted diffusion; clinical signs of infection |
| Postoperative seroma | Fluid signal (T1 dark, T2 bright); no internal fat signal |
| Phyllodes tumor | Solid mass with internal septations; no fat signal; may grow rapidly |
Board Pearl
Rim enhancement DDx triad: fat necrosis, abscess, and malignancy. Fat necrosis = fat signal inside. Abscess = fluid signal inside + restricted diffusion + fever. Malignancy = no fat, no fluid, restricted diffusion, irregular margins. The T1 non-fat-suppressed sequence and DWI separate all three.
Pitfalls and Common Mistakes
- Forgetting to check non-fat-suppressed T1W — the most common miss; enhancement alone can look malignant
- Evolving fat necrosis — new or increasing enhancement months to years after surgery does NOT imply recurrence if internal fat is present
- Mixed fat necrosis and fibrosis — at surgical sites, fat necrosis may coexist with scar tissue, producing confusing mixed signal; focus on identifying any definitive fat component
- Fat-suppression failure — chemical shift artifacts or incomplete fat suppression may obscure the fat signal; compare with known subcutaneous fat on the same sequence
- Small foci — tiny foci of fat necrosis may lack sufficient voxels to definitively identify fat signal; short-interval follow-up or targeted ultrasound may be needed
Board Pearl
Fat necrosis can develop years after surgery or radiation and present as a “new enhancing lesion” on surveillance MRI. If fat signal is present internally on T1W, this is fat necrosis regardless of timing. Do NOT biopsy based on temporal concern alone.
Clinical Significance and Management
- BI-RADS 2 (Benign) when classic features are present (internal fat signal + appropriate clinical history)
- BI-RADS 3 (Probably Benign) if enhancement is atypical and fat signal is equivocal — 6-month follow-up MRI
- BI-RADS 4 and biopsy only if no fat signal can be identified and features are suspicious
- No treatment required; reassurance and routine screening follow-up
- Mammographic correlation with targeted views may demonstrate diagnostic oil cyst or calcifications
v2025 Classification
In BI-RADS v2025, fat necrosis is listed under Other Findings — Typically Benign, reinforcing that when classic imaging features are present, this finding should be assessed as benign without need for tissue sampling.